Middletown, NY, United States of America

Raymond W Leidich



 

Average Co-Inventor Count = 13.0

ph-index = 4

Forward Citations = 191(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Raymond W Leidich

Introduction

Raymond W Leidich is a notable inventor based in Middletown, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of 4 patents to his name, Leidich's work has the potential to impact various medical treatments.

Latest Patents

Among his latest patents is the invention of high affinity human antibodies to the human IL-4 receptor. This invention includes an isolated human antibody or antigen-binding fragment that binds to the human interleukin-4 receptor alpha (hIL-4Rα) with an affinity constant (K) of less than 200 pM, as measured by surface plasmon resonance. Additionally, his work provides methods for treating diseases or disorders that can be improved by reducing interleukin-4 (IL-4) activity. The methods involve administering an antibody or antigen-binding fragment that specifically binds to the human IL-4 receptor.

Career Highlights

Leidich is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to innovate and contribute to the field of medical research. His expertise in antibody development has positioned him as a valuable asset in the biotechnology sector.

Collaborations

Some of his notable coworkers include Sean Stevens and Tammy T Huang, who collaborate with him on various projects within the company.

Conclusion

Raymond W Leidich's contributions to biotechnology through his patents and work at Regeneron Pharmaceuticals, Inc. highlight his role as an influential inventor in the field. His innovations in human antibodies are paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…